These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16671259)

  • 1. [Recombinant activated factor VII in the postanesthetic recovery unit: review of 16 cases].
    Etxániz Alvarez A; Pita Zapata E; Rama Maceiras P; Duro Tacón J; Pose Cambeiro P
    Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):159-62. PubMed ID: 16671259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
    Raivio P; Suojaranta-Ylinen R; Kuitunen AH
    Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
    Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII in critical bleeding after orthotopic liver transplantation.
    Busani S; Semeraro G; Cantaroni C; Masetti M; Marietta M; Girardis M
    Transplant Proc; 2008; 40(6):1989-90. PubMed ID: 18675109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
    Payne EM; Brett SJ; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery.
    Hyllner M; Houltz E; Jeppsson A
    Eur J Cardiothorac Surg; 2005 Aug; 28(2):254-8. PubMed ID: 15935687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
    Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
    J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.
    Lodge JP; Jonas S; Jones RM; Olausson M; Mir-Pallardo J; Soefelt S; Garcia-Valdecasas JC; McAlister V; Mirza DF;
    Liver Transpl; 2005 Aug; 11(8):973-9. PubMed ID: 16035095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
    von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
    Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.
    Planinsic RM; van der Meer J; Testa G; Grande L; Candela A; Porte RJ; Ghobrial RM; Isoniemi H; Schelde PB; Erhardtsen E; Klintmalm G; Emre S
    Liver Transpl; 2005 Aug; 11(8):895-900. PubMed ID: 16035081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
    Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
    McCall P; Story DA; Karalapillai D
    Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.
    Masud F; Bostan F; Chi E; Pass SE; Samir H; Stuebing K; Liebl MG
    J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):28-33. PubMed ID: 18948033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
    Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.